Correlation Between Ensysce Biosciences and Jasper Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Ensysce Biosciences and Jasper Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ensysce Biosciences and Jasper Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ensysce Biosciences and Jasper Therapeutics, you can compare the effects of market volatilities on Ensysce Biosciences and Jasper Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ensysce Biosciences with a short position of Jasper Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ensysce Biosciences and Jasper Therapeutics.

Diversification Opportunities for Ensysce Biosciences and Jasper Therapeutics

0.18
  Correlation Coefficient

Average diversification

The 3 months correlation between Ensysce and Jasper is 0.18. Overlapping area represents the amount of risk that can be diversified away by holding Ensysce Biosciences and Jasper Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Jasper Therapeutics and Ensysce Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ensysce Biosciences are associated (or correlated) with Jasper Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Jasper Therapeutics has no effect on the direction of Ensysce Biosciences i.e., Ensysce Biosciences and Jasper Therapeutics go up and down completely randomly.

Pair Corralation between Ensysce Biosciences and Jasper Therapeutics

Given the investment horizon of 90 days Ensysce Biosciences is expected to generate 0.52 times more return on investment than Jasper Therapeutics. However, Ensysce Biosciences is 1.91 times less risky than Jasper Therapeutics. It trades about -0.04 of its potential returns per unit of risk. Jasper Therapeutics is currently generating about -0.05 per unit of risk. If you would invest  247.00  in Ensysce Biosciences on May 3, 2025 and sell it today you would lose (38.00) from holding Ensysce Biosciences or give up 15.38% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Ensysce Biosciences  vs.  Jasper Therapeutics

 Performance 
       Timeline  
Ensysce Biosciences 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Ensysce Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest inconsistent performance, the Stock's basic indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders.
Jasper Therapeutics 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Jasper Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in September 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Ensysce Biosciences and Jasper Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Ensysce Biosciences and Jasper Therapeutics

The main advantage of trading using opposite Ensysce Biosciences and Jasper Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ensysce Biosciences position performs unexpectedly, Jasper Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Jasper Therapeutics will offset losses from the drop in Jasper Therapeutics' long position.
The idea behind Ensysce Biosciences and Jasper Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.

Other Complementary Tools

Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
AI Portfolio Prophet
Use AI to generate optimal portfolios and find profitable investment opportunities
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum